TL;DR
Get coffee and tea gear delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
Food Safety News’ Oct. 2026 Sunday Edition looks back at cultivated meat’s investment boom and the setbacks that followed, including several startup closures in 2025. The report describes high production costs and investor timelines as obstacles, while the sector’s commercial prospects and the extent of its potential benefits remain uncertain.
Food Safety News’ October 2026 Sunday Edition examines the cultivated-meat sector after a period of heavy investment was followed by several startup shutdowns in 2025. The report says companies have struggled to raise capital and meet commercial milestones, highlighting the gap between ambitious plans for cell-grown meat and the cost and time required to produce it at scale.
The report says cultivated meat and seafood companies attracted more than $2.5 billion in investment from 2021 through 2023, citing the Good Food Institute. It describes that figure as a likely underestimate because investment was moving quickly and was difficult to track. Funding came from venture capital, sovereign wealth funds and established meat companies, including Tyson Foods and JBS. A group of five companies—including Upside Foods, Believer Meats, Wildtype, Aleph Farms and Mosa Meat—received about half of venture capital in 2023, according to the report.
The sector’s subsequent setbacks included the closures of Dutch cultivated-pork company Meatable, UK cell-manufacturing company CellRev and Dutch cultivated-fish-fat startup Upstream Foods in 2025. The report attributes those closures to difficulties including funding needs and failure to meet commercial milestones in time to secure investment.
The report gives particular attention to Believer Meats, which completed a $125 million manufacturing facility near Raleigh, North Carolina. The 200,000-square-foot plant was planned for cultivated chicken production, but the company ceased operations after losing a major financial backer and failing to obtain a last-minute loan, the report says. It says the company shut down before producing anything at the facility.
The Cost of Scaling Cell-Grown Meat
The closures matter because they show that financing a promising technology is different from building a business able to manufacture food at commercial scale. The report says bioreactors require substantial capital, energy and specialized nutrient solutions. Those costs can put pressure on companies well before they reach a steady market or generate sales.
For consumers, the development leaves open when cultivated meat might become widely available, at what price, and in which products. The report describes potential benefits such as producing meat from a small sample of animal cells, but the supplied material does not establish the scale of any such benefits or show that the products can yet compete commercially with conventional meat.
The account also matters to workers and communities connected to planned factories. Believer’s completed North Carolina facility was presented as a major project, but its closure meant the plant did not begin production. The episode illustrates how a company’s funding position can affect local employment expectations as well as investors and suppliers.
bioreactor for cultivated meat production
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
From Investment Boom to Closures
Cultivated meat is made by growing animal cells in a controlled environment rather than raising an entire animal for meat. The report describes cells being collected from a living animal and placed in a culture medium with materials needed for growth, inside a bioreactor. The intended product is designed to resemble conventional meat. The account does not provide production data showing that the process has reached commercial scale.
Interest in the concept predates the recent startup wave. The report recalls a 1931 essay by Winston Churchill, who imagined growing specific parts of a chicken rather than the whole bird. By 2021, investor enthusiasm for cultivated meat had grown substantially, and funding continued through 2023. The later closures, including Believer Meats’ shutdown after building its plant, marked a sharp change from those earlier expectations.
The report says venture funds typically seek returns over roughly five to seven years, while commercial viability for cultivated meat may be at least a decade away or longer. That timing mismatch is offered as one reason investment cooled. It is the report’s account of investor incentives, not a confirmed forecast for every company or product.
““We shall escape the absurdity of growing a whole chicken in order to eat the breast or wing, by growing these parts separately under a suitable medium.””
— Winston Churchill, quoted in the Food Safety News report from his 1931 essay “Fifty Years Hence”
cell culture equipment for food manufacturing
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Commercial Viability Remains Unsettled
The report does not establish when cultivated meat will reach commercial viability, how much it will cost to produce at scale, or whether another company can secure the sustained investment needed to overcome those barriers. Its estimate that viability may be at least a decade away is a broad outlook, not a confirmed timetable.
The supplied report material also does not give current production volumes, retail availability, prices or a complete update on the surviving companies. It mentions animal-welfare potential, but provides no comparative findings that quantify the effect. The status of regulatory approvals across markets is also not detailed; the report says Believer Meats had U.S. government approval before it closed, but that does not establish the regulatory status of other firms or products.
lab-grade nutrient solutions for cell culture
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
What Companies Must Prove
The next test for the sector is whether companies can raise enough money to operate through the long development period and show that production can be scaled at a commercially workable cost. That would require progress beyond facility construction: companies would need to demonstrate reliable manufacturing and a route to customers.
The Sunday Edition does not identify a specific upcoming launch, funding round or regulatory decision. Readers should watch for company announcements, investment disclosures and verified information about production and product availability. Until those details emerge, the closures offer evidence of financial and operational pressure, not proof that cultivated meat as a category has succeeded or failed.
As an affiliate, we earn on qualifying purchases.
Key Questions
What is cultivated meat?
Cultivated meat is produced by growing animal cells in a controlled environment. The Food Safety News report describes cells being placed in a growth medium inside a bioreactor, with the aim of making a product similar to conventional meat.
How much investment did cultivated-meat companies attract?
Citing the Good Food Institute, the report says cultivated meat and seafood companies drew more than $2.5 billion from 2021 through 2023. It says the total was likely an underestimate, but does not provide a revised figure.
Why did some cultivated-meat companies close?
The report describes companies that could not raise needed capital or meet commercial milestones in time to secure investment. It also points to the high costs of biomanufacturing, including energy, bioreactors and specialized growth materials.
Did Believer Meats produce cultivated chicken at its North Carolina plant?
No. The report says Believer Meats ceased operations before producing anything at its completed 200,000-square-foot facility near Raleigh.
When will cultivated meat become widely available?
The report gives no confirmed timetable. It says commercial viability may be at least a decade away or longer, but that is an estimate rather than a fixed forecast, and it does not specify when products will be widely available.
Source: rss
Columbus Day / Indigenous Peoples' Day Picks
long weekend sales
As an affiliate, we earn on qualifying purchases.
